NCT03595891View on ClinicalTrials.gov

The Study of How Long Participants Stay in the Hospital After Receiving Apixaban for a Blood Clot in the Lung

CompletedOBSERVATIONAL
Enrollment

660

Participants

Timeline

Start Date

January 20, 2017

Primary Completion Date

January 29, 2021

Study Completion Date

January 29, 2021

Conditions
Pulmonary Embolism (PE)Pulmonary Thromboembolism
Interventions
OTHER

Non-Interventional

Non-Interventional

Trial Locations (1)

CF23 8RS

Local Institution, Cardiff

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT03595891 - The Study of How Long Participants Stay in the Hospital After Receiving Apixaban for a Blood Clot in the Lung | Biotech Hunter | Biotech Hunter